+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses

Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses

Journal of Immunology 160(11): 5331-5340

Recently, it has been shown that the immunosuppressive macrolide lactone, FK506, exerts good therapeutic efficacy in inflammatory skin diseases.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 018187095

Download citation: RISBibTeXText

PMID: 9605132

Related references

A modified murine local lymph node assay for the differentiation of contact photoallergy from phototoxicity by analysis of cytokine expression in skin-draining lymph node cells. Toxicology. 125(2-3): 149-168,. 6, 1998

Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals. Archives of Toxicology 74(12): 733-744, 2001

Hsp70 vaccination-induced primary immune responses in efferent lymph of the draining lymph node. Vaccine 31(42): 4720-4727, 2013

The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens. Immunology 83(2): 250-255, 1994

Localization of afferent lymph cells within the draining node during a primary immune response. Nature 227(5257): 510-513, 1970

Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40. American Journal of Surgery 179(5): 400-406, 2000

The local lymph node assay: An interlaboratory evaluation of interleukin 6 (IL-6) production by draining lymph node cells. Journal of Applied Toxicology 14(4): 287-291, 1994

Cutting edge: rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells. Journal of Immunology 180(10): 6462-6466, 2008

Effects of oral administration of streptococcal preparation ok 432 on immune responses of draining lymph node cells in colon cancer patients. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 136, 1986

Functional expression of the costimulatory molecule B7 on accessory cells for MHC class I-restricted immune responses. Journal of Investigative Dermatology 101(3): 424, 1993

Effect of vinblastine on the proliferative and immune responses of the lymphoid cells of the draining lymph node and spleen in mice undergoing regional immunization with ram erythrocytes. Farmakologiia i Toksikologiia 50(2): 47-51, 1987

Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: A comparison. Archives of Dermatological Research 288(12): 739-744, 1996

Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cells. Immunology Letters 32(2): 105-110, 1992

CD4(+) T regulatory cells that accumulate in the skin draining lymph nodes of UVB irradiated mice are poised to regulate systemic immune responses. 2007

The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory-signal-providing cells. Cancer Immunology Immunotherapy 40(3): 173-181, 1995